Technology | May 14, 2012

Biosense Webster Partners to Complete Electrophysiology Labs

Agreements with GE, Siemens allow close integration with angiography systems

May 14, 2012 — During the Heart Rhythm Society (HRS) 2012 scientific sessions last week, Biosense Webster Inc. announced it created strategic collaboration agreements with GE Healthcare and Siemens Healthcare. The agreements will make it easier for the vendors to work jointly to create advanced electrophysiology (EP) labs

Biosense Webster, Inc. has developed an image integration solution for electrophysiology (EP) labs around the world. This solution integrates real-time X-ray images, from Siemens Healthcare and GE Healthcare angiography systems, into the company’s Carto 3 3-D electro-anatomical mapping and ablation system. Under the terms of the two agreements, Biosense Webster plans to offer an integrated solution, compatible with both manufacturers’ fluoroscopy systems in 2012.

“Minimizing X-ray exposure for patients and clinicians has long been a focus of healthcare technology manufacturers,” said Shlomi Nachman, worldwide president, cardiovascular care franchise. “These two important strategic agreements will allow Biosense Webster to address the growing need to combine multiple images from different systems in the EP lab into a single display on our CARTO 3 system.”

These latest agreements mark a significant step towards providing a comprehensive, integrated lab solution to electrophysiologists and hospitals around the world. GE Healthcare and Siemens Healthcare collectively, represent more than 50 percent of the installed base of X-ray systems across the globe.

“These strategic collaborations and the resulting technology advancements, continue our commitment to bringing innovation to the cardiac electrophysiology community so they may better serve their patients and protect themselves,” said Nachman.

For more information: www.biosensewebster.com

Related Content

Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Technavio Projects 9 Percent Global Growth for Electrophysiology Therapeutic Devices

Image courtesy of Technavio

News | EP Lab| September 11, 2017
September 11, 2017 — According to the latest market study released by Technavio, the global...
Siemens Healthineers Receives FDA Clearance for TrueFusion Structural Heart Disease Feature
Technology | Cardiovascular Ultrasound| September 06, 2017
The U.S. Food and Drug Administration (FDA) has cleared TrueFusion, a new cardiovascular application from Siemens...
EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion.
News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naïve patients with at
CASTLE-AF Study shows Catheter Ablation of Atrial Fibrillation is First-Line Treatment for Heart Failure Patients. Biotronic Ilivia 7 ICD.

The CASTLE-AF Study shows catheter alation of AF can be used effectively to treat heart failure in patients with an implanted ICD.

News | Atrial Fibrillation| September 01, 2017
September 1, 2017 — Final results from the CASTLE-AF study show a 38 percent reduction in the composite of all-cause
Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices

Abbott. St. Jude Medical has updated its firmware to address cybersecurity issues with its Allure Quadra MP and other EP devices.

Feature | EP Lab| August 29, 2017 | Dave Fornell
August 29, 2017 — The U.S.
Philips is partnering with HeartFlow to co-develop new FFR-CT and FFR-angiography imaging technologies.
News | FFR Technologies| August 28, 2017
August 28, 2017 — Philips Healthcare and HeartFlow Inc.
Overlay Init